ORIC Pharmaceuticals, Inc. (MUN:4TZ) Financings

ORIC Pharmaceuticals, Inc.

Financings

RaiseDate
At-the-market programme of common stock
Closed: US$20M raised
Feb 23, 2026
At-the-market programme of common stock
Closed: US$119M raised
Aug 12, 2025
Private placement of common stock (or pre-funded warrants in lieu thereof)
Announced: about US$125M · US$6.5 a share
Buyers: SR One (leads the financing); Point72; Viking Global Investors; Venrock Healthcare Capital Partners; NEA; Nextech; Vivo Capital; NEXTBio Capital
Use of proceeds: Research and development of clinical-stage product candidates and research programs, working capital and general corporate purposes
May 28, 2025

Read by 6ix AI from the company's releases